An Bioequivalence Study Comparing Nicergoline 10 mg Tablet Manufactured in China With Nicergoline 10 mg Tablet Manufactured in Italy Under Fasted and Fed Conditions in Healthy Chinese Participants
Clinical trial NCT04176367 · COMPLETED
Trial details
- NCT number
- NCT04176367
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-17
- Primary completion
- 2020-09-29
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.